Special News Items

• Cell & Gene Therapy Space Gears Up for First CRISPR Approval
• Gene therapy restores hearing in children with rare form of deafness
• UK biotech AlveoGene launches with plans for inhaled gene therapy
• Gene Therapy Targets Chronic Pain
• Gene therapy eyedrops restored a boy's sight. Similar treatments could help millions
• Gene therapy approved by FDA for certain boys with rare genetic condition
• FDA Needs More Cell, Gene Therapy Mid Managers to Speed Reviews
• Biology Professor Venigalla Rao Makes Breakthrough on Gene Therapy Research
• Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS)
• Bacterial ‘Nanosyringe’ Could Deliver Gene Therapy to Human Cells
• EU approves Hemgenix, one-time gene therapy for hemophilia B
• FDA officials offer advice on gene therapy trials
• New gene therapy delivers treatment directly to brain
• FDA approves Ferring’s Adstiladrin as first gene therapy for bladder cancer
• FDA Approves First Gene Therapy for Hemophilia B
• FDA finalizes neurodegenerative disease gene therapy guidance
• Gene Therapy Rapidly Improves Night Vision in Adults with Congenital Blindness
• Codex DNA's BioXp 9600 System debuting at CAR-TCR Summit
• BioMarin reports cancer case in hemophilia gene therapy trial
• Novartis Confirms Deaths of Two Patients Treated with Gene Therapy Zolgensma
• First patient in the Netherlands successfully treated with stem cell gene therapy
• One-time gene therapy injection could provide HIV treatment that may last a lifetime
• Gene therapy to cure leukemia at one-tenth global costs in the works
• Gene Therapy Successfully Treats Spinal Cord Injuries Without Side Effects
• Updates on gene therapy for ‘bubble boy’ disease and cellular immunotherapy at ASGCT
• AAV Durability: The Road to a One-Shot Cure
• Gene Therapy Sector Needs Better Cell Lines for Vector Production
• Gene Therapy Turns to the Use of Synthetic Biology Principles
• Lentiviral vector-based gene therapy demonstrates long-term safety and efficacy for Wiskott-Aldrich Syndrome
• Nanoscope Therapeutics announces FDA clearance of IND for MCO-010 gene therapy in Stargardt patients